Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

ST. PETERSBURG, Fla. — While the respiratory syncytial virus, known as RSV, is often thought of as a childhood issue, experts said many overlook its impact on adults. As a result, the Centers for ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...

Respiratory syncytial virus (RSV) is a common, highly contagious illness that affects the nose, throat, and lungs. Although RSV usually causes mild illness with cold-like symptoms, the infection can ...

—These investigators found that during a recent winter in England, symptoms and outcomes among older patients with RSV mimicked those seen with influenza. A new hospital-based surveillance study from ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children. But a new study led by a University of Michigan School of Public Health researcher ...

ABRYSVO, a bivalent vaccine, maintained consistently high protective efficacy for both RSV A and RSV B disease through two seasons after a single dose. ABRYSVO efficacy was 77.8% against RSV lower ...

Add Yahoo as a preferred source to see more of our stories on Google. Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being ...

It’s a major cause of respiratory illness in all age groups, but young and old are at greatest risk.

Here's what might be making you sick - and what to do next.

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...